miércoles, 21 de octubre de 2026

Roivant says closely watched immune drug succeeded in new eye disease Non-infectious uveitis was the next test for Lisraya pill

https://www.statnews.com/2026/10/21/roivant-immune-drug-lisraya-noninfectious-uveitis-trial-results/ By Jason MastOct. 21, 2026 General Assignment Reporter

No hay comentarios:

Publicar un comentario